The loss of smell due to Covid-19 infection can be recovered by six genes discovered by Canadian researchers.
The loss of smell, which has evolved into one of the key indicators of infection with the emerging coronavirus, is currently untreatable.
Each of these six genes can be altered using pharmaceuticals, which enables the rapid creation of novel drugs based on them.
According to the researchers, “It might take decades to identify novel treatments for anosmia and put them into clinical practise. While this time can be reduced by developing a medicine based on current pharmaceuticals. ”
Dr. Alexandra Tolstinova, a neurologist, believes that strategies for curing scent loss after “Covid-19” are critical for medicine. Because “smell training” and vitamins may not be sufficient.
The researchers predict that finding new anosmia treatments and implementing them into clinical practise could take decades. However, by creating a medication based on present medications, this time can be cut down.
Finding a method to restore one’s sense of smell following “Covid-19”
About Author
